Clinical Trial

Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia

Name: Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia — clinical trial record (NCT07512700)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is a multicenter, randomized, prospective Phase II clinical trial designed to compare the effectiveness of two treatment approaches for patients with acute monocytic leukemia.

Trial Details

NCT Number	NCT07512700
Lead Sponsor	Chinese PLA General Hospital Collaborators: Air Force Medical Center of PLA, PLA Strategic Support Force's Characteristic Medical Center
Conditions	Acute Monocytic Leukemia
Enrollment	204 participants
Start Date	2025-09-01
Primary Completion	2028-09-30 (estimated)
Study Completion	2029-10-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-06